Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

March 15, PharmAust Manufactured MPL Shipped to the USA for Tableting

News & Announcements 2022By PharmAustMarch 15, 2022

220315_MPLshippedtoUSA

March 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustMarch 1, 2022

220315_Top_Holders

February 21, Ergomed to Assist Covid Trial Commencement

News & Announcements 2022By PharmAustFebruary 22, 2022

220221_Ergomed Investigate COVID Trial

February 18, Appendix 4D and Half Year Update

Financial Reports 2022, News & Announcements 2022By PharmAustFebruary 18, 2022

220218_Appendix4D and Half Year Update

Epichem OHD E-Waste Project – Feb 2022 Presentation to Department of Jobs, Tourism, Science and Innovation

Investor Presentations 2022By PharmAustFebruary 16, 2022

Epichem JTSI e-waste Presentation Final

February 3, Resignation of Epichem CEO

News & Announcements 2022By PharmAustFebruary 3, 2022

220204_Resignation of Epichem CEO

February 2, Monepantel Tablets for Human Clinical Trials

News & Announcements 2022By PharmAustFebruary 2, 2022

220202 Monepantel Tablets for Human Clinical Trials_

February 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustFebruary 1, 2022

220201_Top_Holders_Report

January 31, Appendix 4C and Quarterly Update

News & Announcements 2022By PharmAustJanuary 31, 2022

220130_Appendix 4C and Quarterly

January 1, Top 20 Shareholders

News & Announcements 2022, Top 20 ShareholdersBy PharmAustJanuary 1, 2022

Top_Holders_Report – 2022-01-03T082410.002

12345…
67891011121314151617181920212223242526272829303132333435363738394041424344
45
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
Retweet on Twitter PharmAust Retweeted
pharmaust PharmAust @pharmaust ·
25 Jul

PharmAust is pleased to announce that leading Australian broking and corporate advisory firm, @JPEquityPartner, has updated their research coverage on $PAA
 
A full copy of the research note is available for download here 👉 https://www.pharmaust.com/jp-equity-research-report/

Reply on Twitter 1551424206805405699 Retweet on Twitter 1551424206805405699 3 Like on Twitter 1551424206805405699 13 Twitter 1551424206805405699
Load More
Copyright © 2020 Pharmaust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top